The estimated Net Worth of Joel Lebowitz is at least $79.7 Mille dollars as of 1 September 2021. Mr. Lebowitz owns over 5,574 units of Schrodinger stock worth over $79,727 and over the last 5 years he sold SDGR stock worth over $0. In addition, he makes $0 as Executive Vice President e Chief Financial Officer at Schrodinger.
Joel has made over 12 trades of the Schrodinger stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 5,574 units of SDGR stock worth $24,191 on 1 September 2021.
The largest trade he's ever made was exercising 117,051 units of Schrodinger stock on 19 August 2020 worth over $508,001. On average, Joel trades about 14,022 units every 27 days since 2020. As of 1 September 2021 he still owns at least 3,874 units of Schrodinger stock.
You can see the complete history of Mr. Lebowitz stock trades at the bottom of the page.
Joel A. Lebowitz serves as Executive Vice President, Chief Financial Officer of the Company. Mr. Lebowitz previously spent 26 years at Merck, a pharmaceutical company, where he served as global finance lead, project management from September 2013 to December 2014, executive director, pipeline valuation and portfolio analysis from October 2011 to March 2014 and executive director, corporate planning and management reporting from 2005 to 2011. From January 2015 to October 2018, Mr. Lebowitz was retired. Mr. Lebowitz received a B.A. in Applied Mathematics and Economics from Brown University and an M.B.A. in Finance and International Business from Columbia Graduate School of Business.
Joel Lebowitz is 56, he's been the Executive Vice President e Chief Financial Officer of Schrodinger since 2018. There are 8 older and 13 younger executives at Schrodinger. The oldest executive at Schrodinger, Inc. is Dr. Richard A. Friesner, 68, who is the Co-Founder, Scientific Advisory Chairman and Director.
Joel's mailing address filed with the SEC is C/O SCHRODINGER, INC.,, 120 WEST 45TH STREET, 17TH FLOOR, NEW YORK, NY, 10036.
Over the last 5 years, insiders at Schrodinger have traded over $1,009,056,149 worth of Schrodinger stock and bought 838,235 units worth $14,249,995 . The most active insiders traders include & Melinda Gates Foundation ..., David E Schrodinger Equity ... e Michael Lynton. On average, Schrodinger executives and independent directors trade stock every 10 days with the average trade being worth of $2,459,207. The most recent stock trade was executed by Kenneth Patrick Lorton on 6 March 2024, trading 5,574 units of SDGR stock currently worth $24,191.
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Schrodinger executives and other stock owners filed with the SEC include: